SleepX's DreamIT is a wristband will include several sensors and a vibration motor that will operate with an intensity adapted to the user's reactions to accustom the user to sleep in the correct position using biofeedback.
New York-based smart collar maker Fi announced that it’s adding sleep to the list of the device’s tracking.
Apple’s iOS feature called Night Shift adjusts the screen’s colors to warmer hues after sunset.
Read More
Currently, patients with complete concentric collapse are contraindicated for hypoglossal nerve stimulation OSA therapies.
Read MoreThis revised labeling ensures that patients who receive the Genio system and those already implanted can now undergo full-body 1.5T and 3T MRI diagnostic scans within approved parameters.
Read More
The agreement allows Nyxoah to further develop new neurostimulation technologies for the treatment of sleep-disordered breathing conditions that were invented by Vanderbilt’s David T. Kent, MD.
Read More‘Those who may need an MRI can benefit from Nyxoah’s innovations with no fear for themselves and their implant during the exam.’
Read MoreThe financing will support the expansion of the company’s clinical and commercial operations as it prepares for FDA clearance.
Read MoreNoctrix Health is developing a neuromodulation-based approach to treat RLS and has obtained a Breakthrough Device Designation from the FDA.
Read MoreThe implantation took place at the Nose and Sinus Institute Boca Raton, Fla, and was performed by Melyssa Hancock, MD.
Read MoreThe DREAM (Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea) study is a pivotal, Investigational Device Exemption trial designed to support the marketing authorization of the Genio system in the United States.
Read MoreAerSleep II applies negative pressure over the external surface of the neck to hold the airway open. It is self-contained with an integral vacuum pump.
Read More
After receiving CE certification and following completion of a first-in-human study, keepMed plans to use proceeds to advance keePAP‘s clinical development towards FDA clearance and market launch.
Read MoreHIRREM technology supports the brain to reset from what may have become stuck stress patterns believed to contribute to insomnia.
Read MoreProceeds will allow Signifier to invest further in its solutions for patients with sleep-disordered breathing conditions.
Read More
The scientists had to figure out which of the signals were bouncing off the sleeper’s body, and not bouncing off the mattress.
Read More“He brings a valuable combination of skills and experience that we believe will benefit Signifier not only in the near-term, as we continue the global commercialization of eXciteOSA and Snoozeal, but also in the future as we seek to build a global innovation-led healthcare company.”
Read More